Anthrax Research Today is a free monthly online journal that collates and summarizes the latest research about Anthrax, including details on bacillus anthracis, contagiousness, exposure, effects.

Volume 2 (2006), Issue 9 (September)

1. The use of systemic fluoroquinolones.
   Pediatrics, 118(3): 1287-92. [Abstract] [Full-text]
2. Antibiotic susceptibility and molecular diversity of Bacillus anthracis strains in Chad: detection of a new phylogenetic subgroup.
   J Clin Microbiol, 44(9): 3422-5. [Abstract] [Full-text]
3. Characterization of Bacillus cereus isolates associated with fatal pneumonias: strains are closely related to Bacillus anthracis and harbor B. anthracis virulence genes.
   J Clin Microbiol, 44(9): 3352-60. [Abstract] [Full-text]
4. Polyvalent inhibitors of anthrax toxin that target host receptors.
   Proc Natl Acad Sci U S A, 103(36): 13509-13. [Abstract] [Full-text]
5. Proteomic profiling and identification of immunodominant spore antigens of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis.
   Appl Environ Microbiol, 72(9): 6355-63. [Abstract] [Full-text]
6. Chloroquine prevents T lymphocyte suppression induced by anthrax lethal toxin.
   J Infect Dis, 194(7): 1003-7. [Abstract] [Full-text]
7. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli.
   Vaccine, 24(40): 6405-13. [Abstract] [Full-text]
8. Order out of chaos: the self-organization of communication following the anthrax attacks.
   Health Commun, 20(2): 141-8. [Abstract] [Full-text]
9. Proteomic analyses of murine macrophages treated with Bacillus anthracis lethal toxin.
   Microb Pathog, 41(4): 157-67. [Abstract] [Full-text]
10. Quantitative measurement of anthrax toxin receptor messenger RNA in primary mononuclear phagocytes.
    Microb Pathog, 41(4): 193-8. [Abstract] [Full-text]
11. Inactivation of Bacillus anthracis spores in murine primary macrophages.
    Cell Microbiol, 8(10): 1634-42. [Abstract] [Full-text]
12. Synthesis of potent inhibitors of anthrax toxin based on poly-L-glutamic acid.
    Bioconjug Chem, 17(5): 1265-9. [Abstract] [Full-text]
13. Enhancement of an analytical method for the determination of squalene in anthrax vaccine adsorbed formulations.
    J Pharm Biomed Anal, 42(4): 494-9. [Abstract] [Full-text]
14. Protective antigen as a correlative marker for anthrax in animal models.
    Infect Immun, 74(10): 5871-6. [Abstract] [Full-text]
15. Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity.
    Infect Immun, 74(10): 5840-7. [Abstract] [Full-text]
16. Recombinant protective antigen 102 (rPA102): profile of a second-generation anthrax vaccine.
    Expert Rev Vaccines, 5(4): 417-30. [Abstract] [Full-text]
17. Rabies virus glycoprotein as a carrier for anthrax protective antigen.
    Virology, 353(2): 344-56. [Abstract] [Full-text]
18. Rapid discrimination of Bacillus anthracis from other members of the B. cereus group by mass and sequence of "intact" small acid soluble proteins (SASPs) using mass spectrometry.
    J Microbiol Methods, 67(2): 230-40. [Abstract] [Full-text]
19. Three rare cases of anthrax arising from the same source.
    J Infect, 53(4): e175-9. [Abstract] [Full-text]
20. Application of high-throughput technologies to a structural proteomics-type analysis of Bacillus anthracis.
    Acta Crystallogr D Biol Crystallogr, 62: 1267-75. [Abstract] [Full-text]
21. Use of the internet to enhance infectious disease surveillance and outbreak investigation.
    Biosecur Bioterror, 4(3): 293-300. [Abstract] [Full-text]
22. Reducing mortality from anthrax bioterrorism: strategies for stockpiling and dispensing medical and pharmaceutical supplies.
    Biosecur Bioterror, 4(3): 244-62. [Abstract] [Full-text]
23. Detection and phylogenic analysis of one anthrax virulence plasmid pXO1 conservative open reading frame ubiquitous presented within Bacillus cereus group strains.
    Biochem Biophys Res Commun, 349(4): 1214-9. [Abstract] [Full-text]
24. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.
    Microbiology, 152: 3103-10. [Abstract] [Full-text]
25. Structure-activity relationships of Bacillus cereus and Bacillus anthracis dihydrofolate reductase: toward the identification of new potent drug leads.
    Antimicrob Agents Chemother, 50(10): 3435-43. [Abstract] [Full-text]

© 2005-2008 Anthrax Research Today. All Rights Reserved.